MIRA INFORM REPORT
|
Report Date : |
30.06.2011 |
IDENTIFICATION DETAILS
|
Name : |
GALENICUM HEALTH SL |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
Spain |
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
17.01.2003 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Wholesale of pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
275.830,00 € |
|
Status : |
Good |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Spain |
a2 |
a2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name
GALENICUM HEALTH SL
TAX NUMBER: B63078075
Company situation: Active
EXECUTIVE SUMMARY
Identification
Current Business Name: GALENICUM HEALTH SL
Commercial name: GALENICUM
Other names: YES
Current Address: AVENIDA DIAGONAL, 123 -
PISO 8
Branches: 2
Telephone number: 932011750 Fax: 932011751
URL: www.galenicum.com
Trade Risk
Credit Appraisal: 275.830,00 €
Incidents: NO
R.A.I.: NO
Bank and business defaults of payment - ASNEF EMPRESAS: NO
Financial Information
Balance sheet latest sales (2009): 10.277.908,26 € (Trade Register)
Result: 699.186,91 €
Total Assets: 5.815.756,79 €
Social Capital: 143.180,00 €
Employees: 20
Listed on a Stock Exchange: NO
Commercial Information
Incorporation date: 17/01/2003
Activity: Wholesale of pharmaceutical products
NACE 2009 CODE: 4646
International Operations: Imports and Exports
Corporate Structure
President:
Other Complementary Information
Latest filed accounts published in the Mercantile Register: 2009
Type of Accounts available at the Mercantile Register: Individuals
Latest act published in BORME: 20/05/2011 Annual Filed Accounts
Latest press article: 10/05/2011 EL
ECONOMISTA (SHAREHOLDERS AND HOLDINGS)
Bank Entities: There are
The date when this report was last updated is 29/06/2011.
The information contained in this report has been investigated and
contrasted on 29/06/2011
Credit Appraisal
Maximum Credit
(from 0 to 6,000,000 €)
Favourable to 275.830,00 €
Financial Situation
Exercise:2009
|
Treasury |
Excellent |
|
Indebtedness |
Average |
|
Profitability |
Sufficient |
|
Balance |
Excellent |
Performance
|
Incidents |
None or Negligible |
|
Business
Trajectory |
Good |
INCIDENTS
Summary
LEGAL ACTIONS: No legal actions registered
ADMINISTRATIVE CLAIMS: No administrative claims registered
AFFECTED BY: No significant element.
BANK AND BUSINESS DEFAULTS OF PAYMENT - ASNEF EMPRESAS
R.A.I.
COMPANY NOT REGISTERED IN THE R.A.I.
This company is not registered in the Disputed Bills register (R.A.I.)
DATE AND TIME OF THE CONSULTATION
22/06/2011 14:06:26
Information from the Registro de Aceptaciones Impagados (RAI)- Disputed
Bills register.
It can only be used for information legitimate needs of the consulting
party, in accordance with its social or business activity, in order to grant a
credit or the monitoring or control of the already granted credits and can not
be transmitted or communicated to thirds, nor copied, duplicated, reproduced
nor implemented to any database , owned or external, or reused it in anyway,
direct or indirectly.
FINANCIAL ELEMENTS AND SECTORIAL COMPARATIVE
FINANCIAL ELEMENTS
The shaded amounts in the following financial statements have been converted to the norms established in the PGC2007 derived from RD 1514/2007 and 1515/2007, this way comparatives could be shown with the amounts of exercises initiated from 1/01/08.
Figures given in €
|
|
31/12/2009 (12) BALANCE SHEET |
% ASSETS |
31/12/2008 (12) BALANCE SHEET |
% ASSETS |
31/12/2007 (12) BALANCE SHEET |
% ASSETS |
|
ASSETS |
|
|
|
|
|
|
|
A) NON CURRENT ASSETS |
1.227.207,58 |
21,10 |
911.512,61 |
21,03 |
316.581,18 |
10,54 |
|
B) CURRENT ASSETS |
4.588.549,21 |
78,90 |
3.423.810,10 |
78,97 |
2.685.865,72 |
89,46 |
|
LIABILITIES |
|
|
|
|
|
|
|
A) NET WORTH |
1.940.135,44 |
33,36 |
1.194.974,53 |
27,56 |
1.096.731,05 |
36,53 |
|
B) NON CURRENT LIABILITIES |
883.865,02 |
15,20 |
513.842,52 |
11,85 |
|
|
|
C) CURRENT LIABILITIES |
2.991.756,33 |
51,44 |
2.626.505,66 |
60,58 |
1.905.715,85 |
63,47 |
Profit and Loss
Account Analysis
Figures given in €
|
|
31/12/2009 (12) BALANCE SHEET |
% NET TURNOVER |
31/12/2008 (12) BALANCE SHEET |
% NET TURNOVER |
31/12/2007 (12) BALANCE SHEET |
% NET TURNOVER |
|
SALES |
10.277.908,26 |
|
6.467.926,89 |
|
6.477.173,74 |
|
|
GROSS MARGIN |
2.508.227,96 |
24,40 |
1.812.821,61 |
28,03 |
1.785.955,31 |
27,57 |
|
EBITDA |
701.422,16 |
6,82 |
653.032,70 |
10,10 |
1.089.859,26 |
16,83 |
|
EBIT |
541.959,91 |
5,27 |
565.925,90 |
8,75 |
1.066.370,49 |
16,46 |
|
NET RESULT |
699.186,91 |
6,80 |
459.189,09 |
7,10 |
764.955,14 |
11,81 |
|
EFFECTIVE TAX RATE (%) |
-17,63 |
0,00 |
15,94 |
0,00 |
28,00 |
0,00 |
COMPARATIVE SECTOR ANALYSIS
Values table
Figures expressed in %
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
BALANCE SHEET ANALYSIS: % on the total
assets |
|
|
|
|
ASSETS |
|
|
|
|
A) NON CURRENT ASSETS |
21,10 |
22,56 |
-1,46 |
|
A) CURRENT ASSETS |
78,90 |
77,44 |
1,46 |
|
LIABILITIES |
|
|
|
|
A) NET WORTH |
33,36 |
41,22 |
-7,86 |
|
B) NON CURRENT LIABILITIES |
15,20 |
8,37 |
6,83 |
|
C) CURRENT LIABILITIES |
51,44 |
50,42 |
1,03 |
|
|
|
|
|
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
PROFIT AND LOSS ACCOUNT ANALYSIS: % on the total
operating income |
|
|
|
|
SALES |
87,22 |
98,58 |
-11,36 |
|
GROSS MARGIN |
21,29 |
34,83 |
-13,54 |
|
EBITDA |
5,95 |
6,62 |
-0,66 |
|
EBIT |
4,60 |
4,87 |
-0,27 |
|
NET RESULT |
5,93 |
3,59 |
2,35 |
Sector Composition
Compared sector (NACE 2009): 4646
Number of companies: 112
Size (Sales Figure): 7,000,000.00 - 40,000,000.00 Euros
OTHER DATA FROM THE ANNUAL FINANCIAL REPORT
Results
Distribution
Source: annual financial report 2009
Figures given in €
|
DISTRIBUTION BASE |
APPLICATION A |
||
|
Profit and Loss Account Balance |
699.186,91 |
Legal Reserve |
0,00 |
|
Carry over |
0,00 |
Goodwill reserve |
0,00 |
|
Voluntary reserves |
0,00 |
Special reserves |
0,00 |
|
Other reserves disposable at will |
0,00 |
Voluntary reserves |
549.186,91 |
|
Total of Amounts to be distributed |
699.186,91 |
Dividends |
150.000,00 |
|
|
|
Carry over and others |
0,00 |
|
|
|
Compensation of previous exercises losses |
0,00 |
|
|
|
Application total |
699.186,91 |
Auditing
Source: filing of annual financial statement 2009
Auditors’ opinion: FAVOURABLE
Auditor: CARDONA DEL ALAMO JOSE ANTONIO
Facts subsequent
to the closing
Source: Annual financial report 2009
Posterior to the closure there were no relevant facts that require the
inclusion in the annual accounts.
ADDRESSES
Current Legal Seat Address:
AVENIDA DIAGONAL, 123 - PISO 8
08005 BARCELONA
Previous Seat Address:
AVENIDA DIAGONAL 538 - PLT 4 PTA 1
08006 BARCELONA
|
STREET |
POSTAL CODE |
TOWN |
PROVINCE |
|
AVENIDA CORNELLA, 144 |
08950 |
ESPLUGUES DE LLOBREGAT |
Barcelona |
|
AVENIDA DIAGONAL, 538 - 4ş1 |
08006 |
BARCELONA |
Barcelona |
There are 2 branches registered
|
STREET |
POSTAL CODE |
TOWN |
PROVINCE |
|
CALLE MOSCOU, 14 |
08005 |
BARCELONA |
Barcelona |
There are 1 former branches registered
CORPORATE STRUCTURE
ADMINISTRATIVE LINKS
|
|
|
|
|
|
Distribution of the administration board |
|
|
Governing body : 8 members (latest change:
18/03/2010) Other Positions : 1 (latest change: 11/12/2009) Auditor : 2 (latest change: 18/03/2010) Operative Board Members : 4 (latest change: 14/01/2009) Non-current positions : 3 (latest change: 18/03/2010) |
|
|
Main Board
members, Directors and Auditor
Governing body
|
POSITION |
NAME AND SURNAME |
DATE APPOINTMENT |
|
PRESIDENT |
AOC PARTNERS SL |
18/03/2010 |
|
MANAGING DIRECTOR |
MATARRANIA PARTNERS SL |
18/03/2010 |
|
MEMBER OF THE BOARD |
ALONSO SANZ, ALEJANDRO |
18/03/2010 |
|
MEMBER OF THE BOARD |
ERJAIM ANLAGE SL |
18/03/2010 |
|
|
|
|
Auditor
|
POSITION |
NAME AND SURNAME |
DATE APPOINTMENT |
|
AUDITOR |
CARDONA DEL ALAMO, JOSE ANTONIO |
18/03/2010 |
|
AUDITOR |
HERNANDEZ ESCUDERO, SALOMON |
18/03/2010 |
There are 11 board members, directors and auditors registered
|
POSITION |
NAME AND SURNAME |
|
Manager |
DOMINGO GONZALEZ, JOAQUIN |
|
Financial Manager |
OLLE CORAZON, ALEJANDRO |
|
Human Resources Director |
OLLE CORAZON, ALEJANDRO |
|
Commercial Director |
ALONSO, ALEJANDRO |
FINANCIAL LINKS
|
|
BUSINESS NAME |
CIF / COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
MATARRANIA PARTNERS SL |
B64017585 |
26,67 |
OWN SOURCES |
29/06/2011 |
|
|
AOC PARTNERS SL |
B64013998 |
26,66 |
OWN SOURCES |
29/06/2011 |
|
|
ERJAIM ANLAGE SL |
B64523335 |
21,67 |
OWN SOURCES |
29/06/2011 |
|
|
OLLE CORAZON ALEJANDRO |
|
20,00 |
OWN SOURCES |
29/06/2011 |
|
|
MAXPRO SL |
B43061589 |
5,00 |
OWN SOURCES |
29/06/2011 |
There are 5 direct financial links through shareholders
registered
POTENTIAL LINKS
Search Criterion: ”GALENICUM HEALTH SL”
URL: www.galenicum.com
Pharmaceutical solutions Galenicum. Licensing, outsourcing ... Galenicum
Health SL provides solutions to companies in the Healthcare vertical, mainly
Pharmaceuticals. We are specialized in sourcing and product ...
URL: galenicum.en.chemnet.com
Galenicum Health SL - Aciclovir, Naproxen, Allopurinol, Captopril ... Galenicum
Health SL is manufacturers & exporters of Aciclovir, Naproxen, Allopurinol,
Captopril, Furosemide,
URL: investing.businessweek.com
Galenicum Health, S.L.: Private Company Information - BusinessWeek May 4, 2011
... Galenicum Health, S.L. company research & investing information. Find
executives and the latest company news.
URL: medicamentos.doctissimo.es
GALENICUM HEALTH, S.L. - Doctissimo Ginecología · Medicamentos y embarazo
· Medicamentos genéricos · Medicación infantil · Inicio Medicamentos Guía de
medicamentos GALENICUM HEALTH, S.L. ...
URL: www.vademecum.es
galenicum health, s.l. - Medicamentos Índice de medicamentos \ Por Laboratorio Índice de laboratorio \ Índice Alfabético \ Ficha de GALENICUM HEALTH, S.L.. Regístrate
gratis ...
BUSINESS INFORMATION
Incorporation date: 17/01/2003
Activity: Wholesale of pharmaceutical products
NACE 2009 CODE: 4646
NACE 2009 Activity: Wholesale of pharmaceutical goods
Business: COMERCIO, IMPORTACION, DISTRIBUCION DE MATERIAS
PRIMAS EN EL SECTOR FARMACEUTICO. ELABORACION DE INFORMES Y EL DESARROLLO DE
LAS DEMAS GESTIONES DE TRAMITACION NECESARIAS PARA EL REGISTRO DE MEDICAMENTOS
GENERICOS. ETC
Latest employees figure: 20 (2011)
% of fixed employees: 100,00%
% of women: 100,00%
Employees
evolution
|
|
|
|
Source: Annual financial report 2009
|
CATEGORY |
AVERAGE NUMBER OF EMPLOYEES |
MEN |
WOMEN |
|
Support intellectuals and scientists, technicians and professionals |
|
0 |
2 |
|
Administrative employees |
|
|
2 |
|
ENTITY |
BRANCH |
ADDRESS |
TOWN OR CITY |
PROVINCE |
|
BANCO DE SABADELL, S.A. |
|
|
BARCELONA |
|
|
CAIXA D’ESTALVIS DE CATALUNYA,TARRAGONA I MANRESA |
|
|
BARCELONA |
|
There are 2 bank entities registered
Brand name: ADAIR (Valid)
Type: DENOMINATIVE Scope: NATIONAL
Date: 30/11/2010
There are 1 brands, signs and commercial names
LEGAL STRUCTURE
Constitution Data
Register Date: 17/01/2003
Register town: Barcelona
Announcement number: 90302
Register data:
Volume 35235, Folio 208, Section 8, Sheet 260610,
Inscription I/A 1 (2003-02-06)
Social Capital: 36.000 €
Current structure data
Legal form: Limited Liability Company
Social Capital: 143.180,00 €
Legal Aspects
Obligation to fill in Financial Statements: YES
Chamber census: YES (2009)
B.O.R.M.E.
(OFFICIAL COMPANIES
REGISTRY GAZETTE)
· Acts on activity: 0
· Acts on administrators: 6 (Last: 18/03/2010, first: 04/03/2003)
· Acts on capital: 6 (Last: 16/12/2010, first: 26/05/2004)
· Acts on creation: 1 (Last: 04/03/2003)
· Acts on filed accounts: 7 (Last: 20/05/2011, first: 24/06/2005)
· Acts on identification: 3 (Last: 11/04/2011, first: 27/01/2006)
· Acts on Information: 6 (Last: 18/03/2010, first: 27/01/2006)
·
Latest acts in
B.O.R.M.E.
Most relevant acts of the last twelve months
|
|
ACT |
DATE |
NOTICE NUM. |
TRADE REGISTER |
|
Change of registered address |
11/04/2011 |
159779 |
Barcelona |
|
|
|
New business address: AVENIDA DIAGONAL, 123 - PISO 11 08005 - BARCELONA - Barcelona Register Data: Volume 38728, Folio 79, Section 8, Sheet 260610, Inscription I/A
14 (01/04/2011) Publication Data:
Register Barcelona, Gazette 70, Page
19149, Announcement 159779 (11/04/2011) |
|||
|
Capital reduction |
16/12/2010 |
463022 |
Barcelona |
|
|
|
Amount reduction: 14.320,00 € Subscribed result: 143.180,00 € Register Data:
Volume 38728, Folio 78, Section 8, Sheet 260610, Inscription I/A
13 (01/12/2010) Publication Data:
Register Barcelona, Gazette 239, Page
69366, Announcement 463022 (16/12/2010) |
|||
Other acts
|
ACT |
DATE |
NOTICE NUM. |
TRADE REGISTER |
|
Appointments |
18/03/2010 |
113583 |
Barcelona |
|
Modification of the Articles of Association |
18/03/2010 |
113571 |
Barcelona |
|
Appointments |
18/03/2010 |
113571 |
Barcelona |
|
Resignations |
18/03/2010 |
113571 |
Barcelona |
|
Appointments |
11/12/2009 |
516251 |
Barcelona |
|
Modification of the Articles of Association |
03/12/2008 |
555321 |
Barcelona |
Latest filed accounts
|
ACT |
DATE |
NOTICE NUM. |
TRADE REGISTER |
|
Annual Filed Accounts (2009) |
20/05/2011 |
154533 |
Barcelona |
|
Annual Filed Accounts (2008) |
19/04/2010 |
163317 |
Barcelona |
|
Annual Filed Accounts (2007) |
06/10/2008 |
761536 |
Barcelona |
There are 29 acts registered
PRESS ARTICLES
Press summary by type of information (last five years)
Legal notices: 0
Structural Data: 2 (Last: 10/05/2011, first: 19/01/2011)
Informative data: 0
Financial Information: 0
Negative information: 0
Business lines: 0
Historical press releases: 0
Latest press
article published
10/05/2011 EL
ECONOMISTA (Page 23) SHAREHOLDERS AND HOLDINGS
AZUREBIO ampliará su capital con 800.000 euros, gracias a la inversión
de las empresas del sector farmaceútico GEISER PHARMA y GALENICUM, el fondo de inversión
FITALENT perteneciente a EVERIS, y el fondo REAL DE VELLÓN, gestionado por
CLAVE MAYOR.
19/01/2011 EXPANSIÓN DE CATALUŃA - SHAREHOLDERS
AND HOLDINGS
BIONURE ha cerrado su primera ronda de financiación, valorada en 1,5
millones de euros. Esta operación permitirá financiar los primeros estadios de
investigación de la biotecnológica centrada en la búsqueda de tratamientos
contra la esclerosis múltiple. En la ronda han participado, entre otros,
Joaquim Uriach, Ignasi Biosca, Pascual Nizet y diversas biotecnológicas:
GALENICUM, DIGNA BIOTECH y EL PROUS INSTITUTE FOR BIOMEDICAL RESEARCH. La cía.
ha recibido préstamos y ayudas del Ministerio de Ciencia.
Los fundadores de la empresa, Pablo Villoslada y Albert Zamora controlan
la mayoría del capital.
There are 2 press articles registered for this company
Complementary
Information
Financial Information
El balance cerrado a 31/12/2009 (Deposito 2009) esta disponible en
INFORMA, pero existen datos en los nuevos estados contables incorrectamente
presentados.
El balance cerrado a 31/12/2008 (Deposito 2008) esta disponible en
INFORMA, pero existen datos en los nuevos estados contables incorrectamente
presentados.
FINANCIAL INFORMATION
The information on the last account contained in this report is extracted from the Mercantile Register file of the legal address of the Company and dated 13/04/2011.
The shaded amounts in the following financial statements have been converted to the norms established in the PGC2007 derived from RD 1514/2007 and 1515/2007, this way comparatives could be shown with the amounts of exercises initiated from 1/01/08.
This theoretical conversion exercise has been carried out from the financial statements contained in the accounting information presented on the Trade Register, and elaborated under the accounting norms and principles collected in PGC90 derived from RD 1643/1990, not taking into account any other type of information; for this reason the conversion exercise could include certain inaccuracies.
SITUATION BALANCE-SHEET
Assets
Figures given in €
|
|
31/12/2009 (12) |
% ASSETS |
31/12/2008 (12) |
% ASSETS |
31/12/2007 (12) |
% ASSETS |
|
A) NON CURRENT ASSETS |
1.227.207,58 |
21,10 |
911.512,61 |
21,03 |
316.581,18 |
10,54 |
|
I. Intangible assets |
573.280,59 |
9,86 |
444.276,40 |
10,25 |
285.369,59 |
9,50 |
|
3. Patents, licences , trademarks and similars |
522.910,65 |
8,99 |
404.638,31 |
9,33 |
|
|
|
5. Software |
50.369,94 |
0,87 |
39.638,09 |
0,91 |
|
|
|
II. Tangible fixed assets |
404.814,04 |
6,96 |
409.617,97 |
9,45 |
16.543,21 |
0,55 |
|
2. Technical fittings and other tangible assets |
404.814,04 |
6,96 |
396.417,97 |
9,14 |
|
|
|
3. Fixed assets in progress and advances |
|
|
13.200,00 |
0,30 |
|
|
|
III. Real-estate investments |
|
|
|
|
|
|
|
IV. Long term investments in associated and affiliated companies |
49.168,50 |
0,85 |
49.168,50 |
1,13 |
14.668,38 |
0,49 |
|
1. Net worth instruments |
36.009,00 |
0,62 |
36.009,00 |
0,83 |
|
|
|
2. Credits to companies |
13.159,50 |
0,23 |
13.159,50 |
0,30 |
|
|
|
V. Long Term Financial Investments |
8.449,74 |
0,15 |
8.449,74 |
0,19 |
|
|
|
5. Other financial assets |
8.449,74 |
0,15 |
8.449,74 |
0,19 |
|
|
|
VI. Assets by deferred taxes |
191.494,71 |
3,29 |
|
|
|
|
|
VII. Non current commercial debts |
|
|
|
|
|
|
|
B) CURRENT ASSETS |
4.588.549,21 |
78,90 |
3.423.810,10 |
78,97 |
2.685.865,72 |
89,46 |
|
I. Non-current assets maintained for sale |
|
|
|
|
|
|
|
II. Stocks |
240.112,27 |
4,13 |
318.715,02 |
7,35 |
179.134,91 |
5,97 |
|
1. Goods available for sale |
239.962,27 |
4,13 |
318.565,02 |
7,35 |
|
|
|
6. Pre-payments to suppliers |
150,00 |
0,00 |
150,00 |
0,00 |
|
|
|
III. Trade Debtors and other receivable accounts |
3.250.464,66 |
55,89 |
2.649.830,88 |
61,12 |
2.082.343,54 |
69,35 |
|
1. Clients |
968.891,64 |
16,66 |
1.131.512,26 |
26,10 |
|
|
|
a) Clients for sales and long term services
rendering |
968.891,64 |
16,66 |
1.131.512,26 |
26,10 |
|
|
|
3. Other debts |
2.142.114,12 |
36,83 |
1.147.890,15 |
26,48 |
|
|
|
4. Staff |
|
|
711,62 |
0,02 |
|
|
|
5. Assets by current taxes |
30.698,88 |
0,53 |
30.021,63 |
0,69 |
|
|
|
6. Other credits with the Public Administrations |
108.760,02 |
1,87 |
339.695,22 |
7,84 |
|
|
|
IV. Short term investments in associated and affiliated companies |
|
|
|
|
436,41 |
0,01 |
|
V. Short term financial investments |
652.874,30 |
11,23 |
111.171,06 |
2,56 |
|
|
|
1. Net worth instruments |
299.437,89 |
5,15 |
76.535,44 |
1,77 |
|
|
|
2. Credits to companies |
353.000,00 |
6,07 |
|
|
|
|
|
5. Other financial assets |
436,41 |
0,01 |
6.111,65 |
0,14 |
|
|
|
6. Other investments |
|
|
28.523,97 |
0,66 |
|
|
|
VI. Short term periodifications |
|
|
|
|
|
|
|
VII. Cash and equivalents |
445.097,98 |
7,65 |
344.093,14 |
7,94 |
423.950,86 |
14,12 |
|
1. Treasury |
445.097,98 |
7,65 |
344.093,14 |
7,94 |
|
|
|
TOTAL ASSETS (A + B) |
5.815.756,79 |
100,00 |
4.335.322,71 |
100,00 |
3.002.446,90 |
100,00 |
Alerts associated to the conversion to PGC2007
In the conversion process it has not been
possible to identify the existence of Goodwill nor of goods obtained through
leasing; for this reason the result of the conversion of the financial
statements of the accounts formulation exercise to PGC2007 could include
notable inaccuracies.
Net Worth and
Liabilities
Figures given in €
|
|
31/12/2009 (12) |
% ASSETS |
31/12/2008 (12) |
% ASSETS |
31/12/2007 (12) |
% ASSETS |
|
A) NET WORTH |
1.940.135,44 |
33,36 |
1.194.974,53 |
27,56 |
1.096.731,05 |
36,53 |
|
A-1) Equity |
1.894.161,44 |
32,57 |
1.194.974,53 |
27,56 |
1.096.731,05 |
36,53 |
|
I. Capital |
157.500,00 |
2,71 |
157.500,00 |
3,63 |
148.240,00 |
4,94 |
|
1. Authorized capital |
157.500,00 |
2,71 |
157.500,00 |
3,63 |
148.240,00 |
4,94 |
|
II. Issue premium |
65.608,13 |
1,13 |
65.608,13 |
1,51 |
33.360,00 |
1,11 |
|
III. Reserves |
971.866,40 |
16,71 |
512.677,31 |
11,83 |
150.175,91 |
5,00 |
|
1. Legal and statutory |
31.500,00 |
0,54 |
29.648,00 |
0,68 |
|
|
|
2. Other funds |
940.366,40 |
16,17 |
483.029,31 |
11,14 |
|
|
|
IV. (Net worth own shares and participations) |
|
|
|
|
|
|
|
V. Results from previous years |
|
|
|
|
|
|
|
VI. Other loans from partners |
|
|
|
|
|
|
|
VII. Exercise Result |
699.186,91 |
12,02 |
459.189,09 |
10,59 |
764.955,14 |
25,48 |
|
VIII. (Interim dividend) |
|
|
|
|
|
|
|
IX. Other net worth instruments |
|
|
|
|
|
|
|
A-2) Value changes adjustments |
|
|
|
|
|
|
|
I. Financial assets available for sale |
|
|
|
|
|
|
|
II. Coverage operations |
|
|
|
|
|
|
|
III. Non-current assets and related liabilities, maintained for sale |
|
|
|
|
|
|
|
IV. Conversion differences |
|
|
|
|
|
|
|
V. Other |
|
|
|
|
|
|
|
A-3) Received legacies, grants and subventions |
45.974,00 |
0,79 |
|
|
|
|
|
B) NON CURRENT LIABILITIES |
883.865,02 |
15,20 |
513.842,52 |
11,85 |
|
|
|
I. Long term provisions |
|
|
|
|
|
|
|
II. Long term debts |
881.748,82 |
15,16 |
509.957,32 |
11,76 |
|
|
|
2. Debts with bank entities |
881.748,82 |
15,16 |
259.957,32 |
6,00 |
|
|
|
5. Other financial liabilities |
|
|
250.000,00 |
5,77 |
|
|
|
III. Long term debts with associated and affiliated companies |
|
|
|
|
|
|
|
IV. Liabilities by deferred taxes |
2.116,20 |
0,04 |
3.885,20 |
0,09 |
|
|
|
V. Long term periodifications |
|
|
|
|
|
|
|
VI. Non current trade creditors |
|
|
|
|
|
|
|
VII. Long term debts with special characteristics |
|
|
|
|
|
|
|
C) CURRENT LIABILITIES |
2.991.756,33 |
51,44 |
2.626.505,66 |
60,58 |
1.905.715,85 |
63,47 |
|
I. Liabilities related with non-current assets maintained for sale |
|
|
|
|
|
|
|
II. Short term provisions |
|
|
|
|
|
|
|
III. Short term debts |
24.294,57 |
0,42 |
|
|
|
|
|
5. Other financial liabilities |
24.294,57 |
0,42 |
|
|
|
|
|
IV. Short term debts with associated and affiliated companies |
|
|
|
|
|
|
|
V. Trade creditors and other payable accounts |
2.967.461,76 |
51,02 |
2.626.505,66 |
60,58 |
|
|
|
1. Suppliers |
2.766.360,25 |
47,57 |
1.968.902,88 |
45,42 |
|
|
|
a) Long term suppliers |
2.766.360,25 |
47,57 |
1.968.902,88 |
45,42 |
|
|
|
3. Different creditors |
177.923,05 |
3,06 |
640.752,53 |
14,78 |
|
|
|
4. Staff (pending remunerations) |
2.005,67 |
0,03 |
|
|
|
|
|
6. Other debts with Public Administrations |
21.172,79 |
0,36 |
6.850,25 |
0,16 |
|
|
|
7. Clients pre-payments |
|
|
10.000,00 |
0,23 |
|
|
|
VI. Short term periodifications |
|
|
|
|
|
|
|
VII. Short term debts with special characteristics |
|
|
|
|
|
|
|
TOTAL NET WORTH AND LIABILITIES (A + B + C) |
5.815.756,79 |
100,00 |
4.335.322,71 |
100,00 |
3.002.446,90 |
100,00 |
Alerts associated to the conversion to PGC2007
The Valuation norms applicable to
“Short Term Creditors” have changed and, for this reason, the conversion of
financial statements of the formulation exercise of the accounts to PGC2007
could include notable inaccuracies.
PROFIT AND LOSS
ACCOUNT
Figures given in €
|
|
31/12/2009 (12) |
%OPERATING INCOME |
31/12/2008 (12) |
%OPERATING INCOME |
31/12/2007 (12) |
%OPERATING INCOME |
|
A) CONTINUED OPERATIONS |
|
|
|
|
|
|
|
1. Net Turnover |
10.277.908,26 |
87,22 |
6.467.926,89 |
81,21 |
6.477.173,74 |
83,76 |
|
2. Variation in stocks of finished goods and work in progress |
|
|
|
|
|
|
|
3. Works for its own assets |
|
|
|
|
|
|
|
4. Supplies |
-9.275.451,76 |
-78,71 |
-6.151.787,46 |
-77,24 |
-5.947.229,90 |
-76,91 |
|
5. Other operating income |
1.505.771,46 |
12,78 |
1.496.682,18 |
18,79 |
1.256.011,47 |
16,24 |
|
6. Labour cost |
-268.155,72 |
-2,28 |
-156.217,19 |
-1,96 |
-196.030,30 |
-2,53 |
|
7. Other operating costs |
-1.538.650,07 |
-13,06 |
-1.010.547,20 |
-12,69 |
-500.065,75 |
-6,47 |
|
8. Amortization of fixed assets |
-159.462,25 |
-1,35 |
-87.106,80 |
-1,09 |
-23.488,77 |
-0,30 |
|
9. Allocation of subventions on non financial investments and other |
|
|
|
|
|
|
|
10. Provisions excess |
|
|
|
|
|
|
|
11. Deterioration and result for fixed assets disposal |
|
|
|
|
|
|
|
12. Negative difference of business combinations |
|
|
|
|
|
|
|
13. Other results |
-0,01 |
0,00 |
6.975,48 |
0,09 |
|
|
|
A) OPERATING RESULT (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9 + 10 + 11 + 12
+ 13) |
541.959,91 |
4,60 |
565.925,90 |
7,11 |
1.066.370,49 |
13,79 |
|
14. Financial income |
68.882,69 |
0,58 |
22,32 |
0,00 |
347,17 |
0,00 |
|
b) Other financial income |
68.882,69 |
0,58 |
22,32 |
0,00 |
347,17 |
0,00 |
|
15. Financial expenses |
-39.866,62 |
-0,34 |
-19.179,88 |
-0,24 |
-7.980,04 |
-0,10 |
|
16. Reasonable value variation on financial instruments |
|
|
|
|
|
|
|
17. Exchange differences |
22.197,46 |
0,19 |
-3.371,11 |
-0,04 |
3.737,81 |
0,05 |
|
18. Deterioration and result for disposal of financial instruments |
1.214,25 |
0,01 |
2.875,15 |
0,04 |
|
|
|
19. Other financial income and expenses |
|
|
|
|
|
|
|
B) FINANCIAL RESULT (14 + 15 + 16 + 17 + 18 + 19) |
52.427,78 |
0,44 |
-19.653,52 |
-0,25 |
-3.895,06 |
-0,05 |
|
C) RESULT BEFORE TAXES (A + B) |
594.387,69 |
5,04 |
546.272,38 |
6,86 |
1.062.475,43 |
13,74 |
|
20. Taxes on profits |
104.799,22 |
0,89 |
-87.083,29 |
-1,09 |
-297.520,29 |
-3,85 |
|
B) DISCONTINUED OPERATIONS |
|
|
|
|
|
|
|
D) EXERCISE RESULT (C + 20) |
699.186,91 |
5,93 |
459.189,09 |
5,77 |
764.955,14 |
9,89 |
Alerts associated to the conversion to PGC2007
Valuation norms applicable to Financial
instruments collected in PGC2007 present notable changes with respect to PGC90.
As a consequence, the conversion of the financial statements of the accounts to
PGC2007, carried out considering mainly classification changes in the accounts
might contain certain inaccuracies.
NET WORTH CHANGES STATUS
Status of recognized income and expenses
Figures given in €
|
NET WORTH CHANGES (1/3) |
31/12/2009 (12) |
31/12/2008 (12) |
|
A) PROFIT AND LOSS ACCOUNT RESULT |
699.186,91 |
459.189,09 |
|
INCOME AND EXPENSES ALLOCATED DIRECTLY TO NET WORTH |
|
|
|
I. For valuation of financial instruments |
|
|
|
II. Cash flow coverage |
|
|
|
III. Received legacies, grants and subventions |
|
|
|
IV. For actuarial profits and losses and other adjustments |
|
|
|
V. Non-current assets and related liabilities, maintained for sale |
|
|
|
VI. Conversion differences |
|
|
|
VII. Tax effect |
|
|
|
B) TOTAL INCOME AND EXPENSES ALLOCATED DIRECTLY TO NET WORTH (I + II +
III + IV +V+VI+VII) |
|
|
|
PROFIT AND LOSS ACCOUNT TRANSFERS |
|
|
|
VIII. For valuation of financial instruments |
|
|
|
IX. Cash flow coverage |
|
|
|
X. Received legacies, grants and subventions |
|
|
|
XI. Non-current assets and related liabilities, maintained for sale |
|
|
|
XII. Conversion differences |
|
|
|
XIII. Tax effect |
|
|
|
C) TOTAL TRANSFERS TO THE PROFIT AND LOSS ACCOUNT (VIII + IX + X + XI+
XII+ XIII) |
|
|
|
TOTAL INCOME AND EXPENSES RECOGNIZED (A + B + C) |
699.186,91 |
459.189,09 |
Total net worth
changes status
Figures given in €
|
NET WORTH CHANGES ( 2 /3) |
AUTHORIZED CAPITAL |
ISSUE PREMIUM |
RESERVES |
EXERCISE RESULT |
|
FINAL ACCOUNT BALANCE OF EXERCISE (2007) |
148.240,00 |
33.360,00 |
150.175,91 |
|
|
I. Adjustments by change of criteria in the exercise (2007) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2007) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2008) |
148.240,00 |
33.360,00 |
150.175,91 |
|
|
I. Total recognized income and expenses |
|
|
|
459.189,09 |
|
II. Operations with partners or owners |
|
|
|
|
|
III. Other net worth variations |
9.260,00 |
32.248,13 |
362.501,40 |
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2008) |
157.500,00 |
65.608,13 |
512.677,31 |
459.189,09 |
|
I. Adjustments by change of criteria in the exercise (2008) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2008) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2009) |
157.500,00 |
65.608,13 |
512.677,31 |
459.189,09 |
|
I. Total recognized income and expenses |
|
|
|
699.186,91 |
|
II. Operations with partners or owners |
|
|
|
|
|
III. Other net worth variations |
|
|
459.189,09 |
-459.189,09 |
|
FINAL ACCOUNT BALANCE OF EXERCISE (2009) |
157.500,00 |
65.608,13 |
971.866,40 |
699.186,91 |
|
NET WORTH CHANGES ( 3 /3) |
RECEIVED LEGACIES, GRANTS AND SUBVENTIONS |
TOTAL |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2007) |
|
331.775,91 |
|
|
|
I. Adjustments by change of criteria in the exercise (2007) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2007) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2008) |
|
331.775,91 |
|
|
|
I. Total recognized income and expenses |
|
459.189,09 |
|
|
|
II. Operations with partners or owners |
|
|
|
|
|
III. Other net worth variations |
|
404.009,53 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2008) |
|
1.194.974,53 |
|
|
|
I. Adjustments by change of criteria in the exercise (2008) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2008) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2009) |
|
1.194.974,53 |
|
|
|
I. Total recognized income and expenses |
|
699.186,91 |
|
|
|
II. Operations with partners or owners |
|
|
|
|
|
III. Other net worth variations |
45.974,00 |
45.974,00 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2009) |
45.974,00 |
1.940.135,44 |
|
|
CASH FLOW STATUS
Figures given in €
|
|
31/12/2009 (12) |
31/12/2008 (12) |
|
A) CASH FLOW COMING FROM OPERATING ACTIVITIES |
|
|
|
1. exercise result before taxes |
-594.387,69 |
546.272,38 |
|
2. Results adjustments |
107.034,47 |
106.760,32 |
|
a) Amortization of fixed assets (+) |
159.462,25 |
87.106,80 |
|
f) Results for decline and disposal of financial instruments (+/-) |
-1.214,25 |
-2.875,15 |
|
g) Financial income (-) |
-68.882,69 |
-22,32 |
|
f) Financial expenses (+) |
39.866,62 |
19.179,88 |
|
i) Change difference (+/-) |
-22.197,46 |
3.371,11 |
|
3. Changes in current capital |
374.338,64 |
12.920,61 |
|
a) Stocks (+/-) |
-78.602,75 |
179.430,11 |
|
b) Debtors and other receivable accounts (+/-) |
802.840,11 |
556.775,72 |
|
d) Creditors and other payable accounts (+/-) |
-334.627,89 |
-983.295,34 |
|
e) Other current liabilities (+/-) |
-15.270,83 |
260.010,12 |
|
4. Other cash flow coming from operating activities |
-134.768,92 |
25.838,56 |
|
a) Interests payments (-) |
-108.755,70 |
-19.202,20 |
|
b) Dividends collections (+) |
6,39 |
400.000,00 |
|
d) Collections (payments) for profit tax (+/-) |
-26.019,61 |
-354.959,24 |
|
5. Cash flow coming from operating activities (1 + 2 + 3 + 4) |
-247.783,50 |
691.791,87 |
|
B) CASH FLOW COMING FROM INVESTING ACTIVITIES |
|
|
|
6. Investment payments (-) |
-296.862,51 |
-672.087,61 |
|
a) Group and associated companies |
|
-46.159,50 |
|
b) Intangible assets |
-218.515,75 |
-234.250,36 |
|
c) Tangible assets |
-78.346,76 |
-391.638,01 |
|
e) Other financial assets |
|
-39,74 |
|
7. Disinvestment collections (+) |
159.462,25 |
90.356,18 |
|
b) Intangible assets |
89.511,56 |
75.343,55 |
|
c) Tangible assets |
69.950,69 |
11.763,25 |
|
e) Other financial assets |
|
3.249,38 |
|
8. Cash Flow in investment activities (6 + 7) |
-137.400,26 |
-581.731,43 |
|
C) CASH FLOW COMING FROM FINANCING ACTIVITIES |
|
|
|
9. Net worth instruments collections and payments |
45.974,00 |
9.260,00 |
|
a) Net worth instruments issue (+) |
|
9.260,00 |
|
e) Received legacies, grants and subventions (+) |
45.974,00 |
|
|
10. Financial liabilities instruments collections and payments |
371.791,50 |
-390.042,68 |
|
a) Issue |
2.114.922,39 |
1.630.531,07 |
|
2. Debts with bank entities (+) |
2.114.922,39 |
1.630.531,07 |
|
b) Return and amortization of |
-1.743.130,89 |
-2.020.573,75 |
|
2. Debts with bank entities (-) |
-1.493.130,89 |
-1.370.573,75 |
|
5. Other debts (-) |
-250.000,00 |
-650.000,00 |
|
11. Payments for dividends and remunerations of other net worth
instruments |
|
|
|
12. Cash Flow in financing activities (9 + 10 + 11) |
417.765,50 |
-380.782,68 |
|
D) Exchange rate variations effect |
|
|
|
E) NET CASH OR EQUIVALENTS INCREASE / REDUCTION (5 + 8 + 12 + D) |
32.581,74 |
-270.722,24 |
|
Cash or equivalents at the beginning of the exercise |
344.093,14 |
423.950,86 |
|
Cash or equivalents at the end of the exercise |
101.004,84 |
-694.673,10 |
RATIOS
|
|
31/12/2009 (12) |
CHANGE % |
31/12/2008 (12) |
CHANGE % |
31/12/2007 (12) |
|
BALANCE RATIOS |
|||||
|
Working Capital (€) |
1.596.792,88 |
100,27 |
797.304,44 |
2,20 |
780.149,87 |
|
Working capital ratio |
0,28 |
55,56 |
0,18 |
-30,77 |
0,26 |
|
Soundness Ratio |
1,54 |
17,56 |
1,31 |
-62,14 |
3,46 |
|
Average Collection Period (days) |
114 |
-22,93 |
148 |
27,73 |
116 |
|
Average Payment Period (days) |
99 |
-25,34 |
132 |
|
|
|
LIQUIDITY RATIOS |
|||||
|
Current Ratio (%) |
153,37 |
17,65 |
130,36 |
-7,51 |
140,94 |
|
Quick Ratio (%) |
36,70 |
111,77 |
17,33 |
-22,11 |
22,25 |
|
DEBT RATIOS |
|||||
|
Borrowing percentage (%) |
15,58 |
32,48 |
11,76 |
|
|
|
External Financing Average Cost |
0,04 |
0,00 |
0,04 |
|
|
|
Debt Service Coverage |
-3,66 |
-594,59 |
0,74 |
|
|
|
Interest Coverage |
13,59 |
-53,95 |
29,51 |
-77,92 |
133,63 |
|
GENERAL AND ACTIVITIES RATIOS |
|||||
|
Auto financing generated by sales (%) |
-2,41 |
-122,52 |
10,70 |
-12,08 |
12,17 |
|
Auto financing generated by Assets (%) |
-4,26 |
-126,69 |
15,96 |
-39,22 |
26,26 |
|
Breakdown Point |
1,06 |
-3,64 |
1,10 |
-8,33 |
1,20 |
|
Average Sales Volume per Employee |
1.762.934,52 |
7,94 |
1.633.314,87 |
26,08 |
1.295.434,75 |
|
Average Cost per Employee |
45.995,84 |
16,60 |
39.448,79 |
0,62 |
39.206,06 |
|
Assets Turnover |
1,77 |
18,79 |
1,49 |
-31,02 |
2,16 |
|
Inventory Turnover (days) |
9 |
-50,00 |
19 |
73,33 |
11 |
|
RESULTS RATIOS |
|||||
|
Return on Assets (ROA) (%) |
9,32 |
-28,58 |
13,05 |
-63,26 |
35,52 |
|
Operating Profitability (%) |
12,06 |
-19,92 |
15,06 |
-58,51 |
36,30 |
|
Return on Equity (ROE) (%) |
31,38 |
-31,35 |
45,71 |
-52,82 |
96,88 |
SECTORIAL ANALYSIS
Balance Sheet and Financial Balance
Figures expressed in %
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
BALANCE SHEET ANALYSIS: % on the total
assets |
|
|
|
|
ASSETS |
|||
|
A) NON CURRENT ASSETS |
21,10 |
22,56 |
-1,46 |
|
A) CURRENT ASSETS |
78,90 |
77,44 |
1,46 |
|
LIABILITIES |
|||
|
A) NET WORTH |
33,36 |
41,22 |
-7,86 |
|
B) NON CURRENT LIABILITIES |
15,20 |
8,37 |
6,83 |
|
C) CURRENT LIABILITIES |
51,44 |
50,42 |
1,03 |
|
|
|
|
|
Analytical Account
of Results
Figures given in %
|
|
COMPANY (2009) |
SECTOR |
DIFFERENCE |
|
Net Turnover |
87,22 |
98,58 |
-11,36 |
|
Other operating income |
12,78 |
1,42 |
11,36 |
|
OPERATING INCOME |
100,00 |
100,00 |
0,00 |
|
Supplies |
-78,71 |
-65,34 |
-13,37 |
|
Variation in stocks of finished goods and work in progress |
|
0,17 |
|
|
GROSS MARGIN |
21,29 |
34,83 |
-13,54 |
|
Other operating costs |
-13,06 |
-14,32 |
1,26 |
|
Labour cost |
-2,28 |
-14,25 |
11,97 |
|
GROSS OPERATING RESULT |
5,95 |
6,26 |
-0,31 |
|
Amortization of fixed assets |
-1,35 |
-1,42 |
0,07 |
|
Deterioration and result for fixed assets disposal |
|
0,03 |
|
|
Other expenses / income |
0,00 |
|
|
|
NET OPERATING RESULT |
4,60 |
4,87 |
-0,27 |
|
Financial result |
0,44 |
0,11 |
0,33 |
|
RESULT BEFORE TAX |
5,04 |
4,98 |
0,06 |
|
Taxes on profits |
0,89 |
-1,39 |
2,28 |
|
RESULT COMING FROM CONTINUED OPERATIONS |
5,93 |
|
|
|
NET RESULT |
5,93 |
3,59 |
2,34 |
Main Ratios
|
|
COMPANY (2009) |
PTILE25 |
PTILE50 |
PTILE75 |
|
BALANCE RATIOS |
|
|
|
|
|
Working Capital (€) |
1.596.792,88 |
853.522,48 |
1.896.586,35 |
3.658.494,87 |
|
Working capital ratio |
0,28 |
0,12 |
0,31 |
0,46 |
|
Soundness Ratio |
1,54 |
1,20 |
4,03 |
10,42 |
|
Average Collection Period (days) |
114 |
57 |
93 |
164 |
|
Average Payment Period (days) |
99 |
11 |
33 |
73 |
|
LIQUIDITY RATIOS |
|
|
|
|
|
Current Ratio (%) |
153,37 |
1,18 |
1,57 |
2,07 |
|
Quick Ratio (%) |
36,70 |
0,02 |
0,09 |
0,38 |
|
DEBT RATIOS |
|
|
|
|
|
Borrowing percentage (%) |
15,58 |
3,45 |
23,96 |
44,64 |
|
External Financing Average Cost |
0,04 |
0,01 |
0,05 |
0,08 |
|
Debt Service Coverage |
-3,66 |
0,17 |
2,30 |
8,43 |
|
Interest Coverage |
13,59 |
1,87 |
5,35 |
29,81 |
|
GENERAL AND ACTIVITIES RATIOS |
|
|
|
|
|
Auto financing generated by sales (%) |
-2,41 |
1,29 |
2,93 |
6,56 |
|
Auto financing generated by Assets (%) |
-4,26 |
2,64 |
6,61 |
11,13 |
|
Breakdown Point |
1,06 |
1,01 |
1,03 |
1,08 |
|
Average Sales Volume per Employee |
1.762.934,52 |
198.178,09 |
389.295,59 |
721.288,34 |
|
Average Cost per Employee |
45.995,84 |
31.274,37 |
34.489,86 |
50.816,98 |
|
Assets Turnover |
1,77 |
1,18 |
1,78 |
2,53 |
|
Inventory Turnover (days) |
9 |
31 |
56 |
108 |
|
RESULTS RATIOS |
|
|
|
|
|
Return on Assets (ROA) (%) |
9,32 |
2,66 |
6,67 |
12,53 |
|
Operating Profitability (%) |
12,06 |
4,90 |
9,54 |
15,31 |
|
Return on Equity (ROE) (%) |
31,38 |
5,84 |
19,30 |
32,85 |
ADDITIONAL INFORMATION
Consulted
Sources
Central Trade Register
Mercantile Registrars
Chamber of Commerce / Camerdata
Tax Administration / VIES Consultation
Tax Administration / Consultation by NIF
BOP
INTERNET
Telephone directory: PÁGINAS AMARILLAS
Telephone directory: PÁGINAS BLANCAS
Telephone directory: QDQ
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.94 |
|
UK Pound |
1 |
Rs.71.91 |
|
Euro |
1 |
Rs.64.60 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.